{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:45Z","timestamp":1791262365367,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110485","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:24:15Z","timestamp":1788733455000},"page":"110485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural biology of the dengue virus NS2B\u2013NS3 protease as a target for antiviral drug development"],"prefix":"10.1016","volume":"182","author":[{"given":"Rahit","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeti","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitreyee","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purna Chandra","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110485_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.virs.2025.05.009","article-title":"Eltrombopag, an FDA-approved drug, inhibits dengue virus type 2 by targeting NS2B-NS3 protease","volume":"40","author":"Zhu","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bioorg.2026.110485_bb0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0015","article-title":"Assessing the global dengue burden: incidence, mortality, and disability trends over three decades","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2026.110485_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijregi.2024.100459","article-title":"Global landmark: 2023 marks the worst year for dengue cases with millions infected and thousands of deaths reported","volume":"13","author":"Haider","year":"2024","journal-title":"IJID Regions"},{"key":"10.1016\/j.bioorg.2026.110485_bb0025","article-title":"Animals as potential reservoirs for dengue transmission: a systematic review, one","volume":"12","author":"Gwee","year":"2021","journal-title":"Health"},{"key":"10.1016\/j.bioorg.2026.110485_bb0030","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-024-50437-3","article-title":"Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B\/NS3 and blocks replication organelle formation","volume":"15","author":"Kiemel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110485_bb0035","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1080\/07391102.2023.2192796","article-title":"Identification and validation of novel non-nucleoside class of molecules inhibiting the dengue virus replication","volume":"41","author":"Roy","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.110485_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100604","article-title":"Current status of the development of dengue vaccines","volume":"22","author":"Lee","year":"2025","journal-title":"Vaccine X"},{"key":"10.1016\/j.bioorg.2026.110485_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2301790","article-title":"Live, attenuated, tetravalent Butantan\u2013Dengue vaccine in children and adults","volume":"390","author":"Kall\u00e1s","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110485_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2310\/7060.2004.18503","article-title":"Dengue in Travelers: a review","volume":"11","author":"Wichmann","year":"2006","journal-title":"J. Travel Med."},{"key":"10.1016\/j.bioorg.2026.110485_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B \u2013 NS3 protease \u2013 helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","article-title":"Strategies for development of dengue virus inhibitors","volume":"85","author":"Noble","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.01788-07","article-title":"Crystal structure of the NS3 protease-helicase from dengue virus","volume":"82","author":"Luo","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bioorg.2026.110485_bb0075","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1021\/cr500233q","article-title":"Biochemistry and medicinal chemistry of the dengue virus protease","volume":"114","author":"Nitsche","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110485_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.00855-10","article-title":"Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay","volume":"55","author":"Yang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110485_bb0085","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0090","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jmb.2008.11.026","article-title":"Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation","volume":"385","author":"Robin","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0095","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.272.49.30715","article-title":"Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B","volume":"272","author":"Clum","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0100","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1099\/0022-1317-80-5-1167","article-title":"Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor","volume":"80","author":"Brinkworth","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0105","doi-asserted-by":"crossref","first-page":"19205","DOI":"10.1021\/ja208435s","article-title":"Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus ns2b-ns3 protease: fold analysis by pseudocontact shifts","volume":"133","author":"De La Cruz","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110485_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2026.110485_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01836-16","article-title":"Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments","volume":"91","author":"Wu","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2017.03.107","article-title":"Discovering key residues of dengue virus NS2b-NS3-protease: new binding sites for antiviral inhibitors design","volume":"492","author":"Aguilera-Pesantes","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.110485_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7150\/ijms.29938","article-title":"The conserved molecular determinants of virulence in dengue virus","volume":"16","author":"Ahmad","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bioorg.2026.110485_bb0130","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/cb400612h","article-title":"Allosteric inhibition of the NS2B-NS3 protease from dengue virus","volume":"8","author":"Yildiz","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0135","first-page":"1","article-title":"Discovery of azaleatin as a potential allosteric inhibitor for dengue NS2B-NS3 protease using in vitro and in silico studies","volume":"0","author":"Mustafa","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.110485_bb0140","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0145","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1074\/jbc.M112.442723","article-title":"NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex","volume":"288","author":"Kim","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0150","first-page":"8235","article-title":"Nucleic acids research nucleic acids research","volume":"12","author":"Murray","year":"1980","journal-title":"Methods"},{"key":"10.1016\/j.bioorg.2026.110485_bb0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0160","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110485_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/v16121926","article-title":"Discovery of potent dengue virus NS2B-NS3 protease inhibitors among Glycyrrhizic acid conjugates with amino acids and dipeptides esters","volume":"16","author":"Lin","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110485_bb0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14756366.2017.1355791","article-title":"Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities","volume":"32","author":"Pelliccia","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0175","series-title":"Flavivirus NS2B\/NS3 Protease: Structure, Function, and Inhibition","author":"Li","year":"2017"},{"key":"10.1016\/j.bioorg.2026.110485_bb0180","first-page":"1","article-title":"Inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses","volume":"69","author":"Murtuja","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110485_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-025-02622-z","article-title":"Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches","volume":"22","author":"Khan","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2026.110485_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph18040566","article-title":"Identification of potential inhibitors targeting non-structural proteins NS3 and NS5 of dengue virus using docking and deep learning approaches","volume":"18","author":"Hossain","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110485_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132855","article-title":"Identification of novel and potential inhibitors against the dengue virus NS2B\/NS3 protease using virtual screening and biomolecular simulations","volume":"272","author":"Nasir","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/chem-2024-0004","article-title":"Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus","volume":"22","author":"Mujwar","year":"2024","journal-title":"Open Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0205","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1128\/JVI.02044-09","article-title":"Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family","volume":"84","author":"Chandramouli","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0210","doi-asserted-by":"crossref","unstructured":"J. Lei, G. Hansen, C. Nitsche, C.D. Klein, L. Zhang, R. Hilgenfeld, Crystal structure of zika virus NS2B-NS3 protease in complex with a boronate inhibitor, Science (1979). 353 (2016) 503\u2013505. doi:https:\/\/doi.org\/10.1126\/science.aag2419.","DOI":"10.1126\/science.aag2419"},{"key":"10.1016\/j.bioorg.2026.110485_bb0215","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/jm800503y","article-title":"Potent cationic inhibitors of West Nile virus NS2B\/NS3 protease with serum stability, cell permeability and antiviral activity","volume":"51","author":"Stoermer","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 1: warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0225","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","article-title":"The medicinal chemistry of dengue virus","volume":"59","author":"Behnam","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0072402","article-title":"New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation","volume":"8","author":"de Almeida","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110485_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmgm.2015.05.008","article-title":"Binding specificity of polypeptide substrates in NS2B\/NS3pro serine protease of dengue virus type 2: a molecular dynamics study","volume":"60","author":"Yotmanee","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2026.110485_bb0240","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/acsinfecdis.6b00131","article-title":"Dengue protease substrate recognition: binding of the prime side","volume":"2","author":"Lin","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110485_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-17-68","article-title":"Structure-guided mutagenesis of active site residues in the dengue virus two-component protease NS2B-NS3","volume":"17","author":"Salaemae","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bioorg.2026.110485_bb0250","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/JVI.01325-08","article-title":"Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays","volume":"83","author":"Zuo","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0255","doi-asserted-by":"crossref","unstructured":"Z. Zhang, Y. Li, Y.R. Loh, W.W. Phoo, A.W. Hung, C.B. Kang, D. Luo, Crystal structure of unlinked NS2B-NS3 protease from zika virus, Science (1979). 354 (2016) 1597\u20131600. doi:https:\/\/doi.org\/10.1126\/science.aai9309.","DOI":"10.1126\/science.aai9309"},{"key":"10.1016\/j.bioorg.2026.110485_bb0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BSR20100142","article-title":"Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target","volume":"31","author":"Phong","year":"2011","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bioorg.2026.110485_bb0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10822-010-9326-8","article-title":"Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of dengue virus NS2B-NS3 protease","volume":"24","author":"Frecer","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.110485_bb0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2016.04.008","article-title":"European journal of medicinal chemistry Progress and prospects on DENV protease inhibitors","volume":"117","author":"Timiri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0275","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","article-title":"A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication","volume":"440","author":"Pambudi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2026.110485_bb0280","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11030-024-10899-5","article-title":"Evaluation of methoxyflavones as dengue NS2B\u2013NS3 protease inhibitors: an in silico and in vitro studies","volume":"29","author":"Mustafa","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110485_bb0285","article-title":"Medicinal chemistry insights of molecular docking and cell permeability mechanism of phytoconstituents present in Mimosa pudica as NS2B - NS3 protease inhibitors against dengue virus","author":"Prasad","year":"2025","journal-title":"Discover Chemistry"},{"key":"10.1016\/j.bioorg.2026.110485_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111040","article-title":"3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B\/NS3 protease inhibitors","volume":"396","author":"Jitonnom","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.110485_bb0295","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","article-title":"Structure-based discovery of dengue virus protease inhibitors","volume":"82","author":"Tomlinson","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10822-011-9418-0","article-title":"Structure-guided fragment-based in silico drug design of dengue protease inhibitors","volume":"25","author":"Knehans","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.110485_bb0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0315","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.str.2018.02.005","article-title":"Structural insights into the inhibition of zika virus NS2B-NS3 protease by a small-molecule inhibitor","volume":"26","author":"Li","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.110485_bb0320","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.str.2017.06.006","article-title":"Structural dynamics of zika virus NS2B-NS3 protease binding to dipeptide inhibitors","volume":"25","author":"Li","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.110485_bb0325","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","article-title":"Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)- one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of dengue and West Nile virus NS2B\/NS3 proteases","volume":"21","author":"Lai","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0330","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","article-title":"Flavonoids as noncompetitive inhibitors of dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies","volume":"23","author":"De Sousa","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0335","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1386207319666160506123715","article-title":"An in-silico investigation of phytochemicals as antiviral agents against dengue fever","volume":"19","author":"Powers","year":"2016","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2026.110485_bb0340","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.3390\/ijms25084376","article-title":"The inhibition of NS2B\/NS3 protease: a new therapeutic opportunity to treat dengue and zika virus infection","volume":"25","author":"Starvaggi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110485_bb0345","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-based allosteric inhibitors of zika and dengue virus NS2B\/NS3 proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116392","article-title":"SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases","volume":"47","author":"Maus","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0355","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease","volume":"141","author":"Yao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110485_bb0360","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/acsmedchemlett.8b00316","article-title":"One step beyond: Design of Substrates Spanning Primed Positions of zika virus NS2B-NS3 protease","volume":"9","author":"Gruba","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2019.05.004","article-title":"Exploiting the unique features of zika and dengue proteases for inhibitor design","volume":"166","author":"Majerov\u00e1","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2026.110485_bb0370","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent Progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0375","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0380","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0167-7799(00)88999-4","article-title":"Recent developments in retro peptides and proteins \u2014 an ongoing topochemical exploration","volume":"13","author":"Chorev","year":"1995","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0385","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41598-018-24517-6","article-title":"Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides","volume":"8","author":"Arranz-Gibert","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110485_bb0390","doi-asserted-by":"crossref","first-page":"8389","DOI":"10.1021\/jm400828u","article-title":"Thiazolidinone\u2013peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture","volume":"56","author":"Nitsche","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0395","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/ml500245v","article-title":"C-terminal residue optimization and fragment merging: discovery of a potent peptide-hybrid inhibitor of dengue protease","volume":"5","author":"Behnam","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0400","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","article-title":"Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-Benzyloxyphenylglycine residue","volume":"58","author":"Behnam","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0405","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","article-title":"Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors","volume":"58","author":"Weigel","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0410","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2011.07.002","article-title":"Tripeptide inhibitors of dengue and West Nile virus NS2B\u2013NS3 protease","volume":"92","author":"Sch\u00fcller","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0415","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrd2590","article-title":"The exploration of macrocycles for drug discovery--an underexploited structural class","volume":"7","author":"Driggers","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110485_bb0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond the rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110485_bb0425","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1016\/j.bmcl.2017.05.027","article-title":"Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity","volume":"27","author":"Takagi","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0430","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0435","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmc.2004.09.036","article-title":"Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases","volume":"13","author":"Ganesh","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110485_bb0445","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1021\/jm300655h","article-title":"Critical effect of peptide cyclization on the potency of peptide inhibitors against dengue virus NS2B-NS3 protease","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0450","doi-asserted-by":"crossref","unstructured":"H. TERLAU, B.M. OLIVERA, Conus venoms: a rich source of novel ion channel-targeted peptides, Physiol. Rev. 84 (2004) 41\u201368. doi:https:\/\/doi.org\/10.1152\/physrev.00020.2003.","DOI":"10.1152\/physrev.00020.2003"},{"key":"10.1016\/j.bioorg.2026.110485_bb0455","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2015.03.010","article-title":"Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay","volume":"118","author":"Chu","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","article-title":"Structural biology of dengue virus enzymes: towards rational design of therapeutics","volume":"96","author":"Noble","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0465","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.bbamem.2015.06.010","article-title":"Membrane topology of NS2B of dengue virus revealed by NMR spectroscopy","volume":"1848","author":"Li","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bioorg.2026.110485_bb0470","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/1873-3468.12741","article-title":"Structural characterization of the linked <scp>NS<\/scp> 2B- <scp>NS<\/scp> 3 protease of zika virus","volume":"591","author":"Li","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126965","article-title":"Inhibitors of the zika virus protease NS2B-NS3","volume":"30","author":"Voss","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110485_bb0480","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110485_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104707","article-title":"Identification and structural characterization of small molecule fragments targeting zika virus NS2B-NS3 protease","volume":"175","author":"Quek","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10858-013-9740-z","article-title":"Fragment-based drug discovery using NMR spectroscopy","volume":"56","author":"Harner","year":"2013","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.bioorg.2026.110485_bb0495","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2017.09.008","article-title":"STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease","volume":"146","author":"Sch\u00f6ne","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110485_bb0500","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide\u2013boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0505","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1021\/jm300146f","article-title":"Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping","volume":"55","author":"Deng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0510","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/v13040659","article-title":"Melatonin inhibits dengue virus infection via the Sirtuin 1-mediated interferon pathway","volume":"13","author":"Morchang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110485_bb0515","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01309858","article-title":"Protective effects of melatonin in mice infected with encephalitis viruses","volume":"140","author":"Ben-Nathan","year":"1995","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144321","article-title":"Doxycycline interferes with zika virus serine protease and inhibits virus replication in human skin fibroblasts","volume":"26","author":"Chong Teoh","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110485_bb0525","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/1995-7645.391777","article-title":"Role of doxycycline in the treatment of dengue infection: an open-label, randomized, controlled, pilot trial","volume":"17","author":"Kumar","year":"2024","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.bioorg.2026.110485_bb0530","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12868-023-00832-1","article-title":"Melatonin inhibits Japanese encephalitis virus replication and neurotoxicity via calcineurin-autophagy pathways","volume":"24","author":"Moon","year":"2023","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bioorg.2026.110485_bb0535","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/molecules29174047","article-title":"Orthoflaviviral inhibitors in clinical trials, preclinical in vivo efficacy targeting NS2B-NS3 and cellular antiviral activity via competitive protease inhibition","volume":"29","author":"Cavina","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110485_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113362","article-title":"Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b\/NS3 protease","volume":"202","author":"Saqallah","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2026.110485_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55723-5","article-title":"Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against dengue virus NS2B-NS3 protease","volume":"9","author":"Bharadwaj","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110485_bb0550","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/tcr.10058","article-title":"Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions","volume":"3","author":"Shiao","year":"2003","journal-title":"Chem. Rec."},{"key":"10.1016\/j.bioorg.2026.110485_bb0555","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1387-2656(07)13010-6","article-title":"Ganoderma lucidum and its pharmaceutically active compounds","volume":"13","author":"Boh","year":"2007","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.bioorg.2026.110485_bb0560","doi-asserted-by":"crossref","unstructured":"S. Y., Natural DENV-2 NS2B\/NS3 protease inhibitors from Myristica cinnamomea king, Trop. Biomed. 38 (2021) 79\u201384. doi:10.47665\/tb.38.2.044.","DOI":"10.47665\/tb.38.2.044"},{"key":"10.1016\/j.bioorg.2026.110485_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.610912","article-title":"Dengue fever: therapeutic potential of Carica papaya L. leaves","volume":"12","author":"Sarker","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/616737","article-title":"Carica papaya leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever","volume":"2013","author":"Subenthiran","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bioorg.2026.110485_bb0575","doi-asserted-by":"crossref","unstructured":"K. NHV, Structural analysis and molecular modeling studies of fatty acids and peptides binding with NS2B\/NS3 dengue protease, J. Emerg. Dis. Virol. 2 (2016). doi:10.16966\/2473-1846.121.","DOI":"10.16966\/2473-1846.121"},{"key":"10.1016\/j.bioorg.2026.110485_bb0580","first-page":"636","article-title":"Metabolite profiling and in vitro evaluation of Lepisanthes fruticosa fruit pulp extract as inhibitor against dengue and West Nile virus NS2B-NS3 proteases","volume":"17","author":"Suhaina Supian","year":"2021","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.bioorg.2026.110485_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000561","article-title":"NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease","volume":"3","author":"Su","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2026.110485_bb0590","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13102818.2019.1578184","article-title":"Potential anti-viral compounds from Malaysian plant natural product repository and database (MyNature50000) for DENV2","volume":"33","author":"Zakaria","year":"2019","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.bioorg.2026.110485_bb0595","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1021\/jf100369h","article-title":"Pressurized liquid extraction as an alternative process to obtain antiviral agents from the edible microalga Chlorella vulgaris","volume":"58","author":"Santoyo","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2026.110485_bb0600","series-title":"Possible anti-viral effects of neem (Azadirachta indica) on dengue virus","author":"Rao","year":"2020"},{"key":"10.1016\/j.bioorg.2026.110485_bb0605","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1002\/chem.201900591","article-title":"Stachyonic acid: a dengue virus inhibitor from Basilicum polystachyon, chemistry \u2013 a","volume":"25","author":"Tan","year":"2019","journal-title":"European Journal"},{"key":"10.1016\/j.bioorg.2026.110485_bb0610","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00705-018-3769-y","article-title":"Inhibitory effect of the green tea molecule EGCG against dengue virus infection","volume":"163","author":"Raekiansyah","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioorg.2026.110485_bb0615","article-title":"Chemical constituents from Endiandra kingiana (Lauraceae) as potential inhibitors for dengue type 2 NS2B\/NS3 serine protease and its molecular docking","volume":"14","author":"Sulaiman","year":"2019","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bioorg.2026.110485_bb0620","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbadis.2014.10.005","article-title":"The molecular targets of resveratrol","volume":"1852","author":"Kulkarni","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.bioorg.2026.110485_bb0625","doi-asserted-by":"crossref","unstructured":"J.-X. Chen, H.-J. Xue, W.-C. Ye, B.-H. Fang, Y.-H. Liu, S.-H. Yuan, P. Yu, Y.-Q. Wang, Activity of Andrographolide and Its Derivatives against Influenza Virus <i>in Vivo<\/i> and <i>in Vitro<\/i>, Biol. Pharm. Bull. 32 (2009) 1385\u20131391. doi:https:\/\/doi.org\/10.1248\/bpb.32.1385.","DOI":"10.1248\/bpb.32.1385"},{"key":"10.1016\/j.bioorg.2026.110485_bb0630","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship","volume":"39","author":"Lim","year":"2017","journal-title":"Biotechnol. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:18:13Z","timestamp":1791260293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":126,"alternative-id":["S0045206826010217"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110485","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural biology of the dengue virus NS2B\u2013NS3 protease as a target for antiviral drug development","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110485"}}